TSE Health Center

Philippe De Donder, Marie-Louise Leroux, and François Salanié, “Advantageous selection without moral hazard (with an application to life care annuities)”, TSE Working Paper, n. 22-1334, May 2022.

James K. Hammitt, “Prevention, Treatment, and Palliative Care: The Relative Value of Health Improvements under Alternative Evaluation Frameworks”, TSE Working Paper, n. 22-1339, May 2022.

Pierre Dubois, Ashvin Gandhi, and Shoshana Vasserman, “Bargaining and International Reference Pricing in the Pharmaceutical Industry”, TSE Working Paper, n. 22-1338, April 2022.

Pham Hoang Uyen, Vo Thi Le Uyen, Pham Van Chung, Stéphane Cezera, and Manh-Hung Nguyen, “Covid-19 Pandemic and Performance of Economic Sectors in Vietnam”, TSE Working Paper, n. 22-1304, February 2022.

Philippe De Donder, Humberto Llavador, Stefan Penczynski, John E. Roemer, and Roberto Vélez, “A game-theoretic analysis of childhood vaccination behavior: Nash versus Kant”, TSE Working Paper, n. 21-1278, December 2021.

Philippe De Donder, Bertrand Achou, Franca Glenzer, Minjoon Lee, and Marie-Louise Leroux, “Nursing home aversion post-pandemic: Implications for savings and long-term care policy”, TSE Working Paper, n. 21-1249, September 2021.

Catarina Goulão, and Agustín Pérez-Barahona, “Health capital norms and intergenerational transmission of non-communicable chronic diseases”, TSE Working Paper, n. 21-1236, July 2021.

David Bardey, Arturo Harker, and Daniela Zuluaga, “Price cap regulation in the Colombian pharmaceutical market: An impact evaluation”, TSE Working Paper, n. 21-1195, March 2021.

David Bardey, Manuel Fernandez, and Alexis Gravel, “Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at least) in the Short Run?”, TSE Working Paper, n. 21-1189, February 2021.

James K. Hammitt, and Nicolas Treich, “Fatality Risk Regulation”, TSE Working Paper, n. 21-1177, January 2021.